Panel Supports Smith & Nephew’s Birmingham Hip Resurfacing System
This article was originally published in The Gray Sheet
Executive Summary
FDA's Orthopaedic & Rehabilitation Devices Panel narrowly recommended approval for Smith & Nephew's Birmingham Hip Resurfacing system Sept. 8, provided that the firm conducts a postmarket study